Latest Articles

Publication Date
Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials - Stock Titan

Acrivon's Cancer Drug Pipeline Advances with Tumor Response in Endometrial Cancer Trials Stock Titan

Published: Aug. 13, 2025, 8:15 p.m.
Q&A: Endometrial Cancer - Medscape

Q&A: Endometrial Cancer Medscape

Published: Aug. 13, 2025, 2:13 p.m.
Dosimetry, Toxicity, and Outcomes of Medically Inoperable Endometrial Cancer Treated With Definitive External Beam Radiation Therapy and Brachytherapy - Cureus

Dosimetry, Toxicity, and Outcomes of Medically Inoperable Endometrial Cancer Treated With Definitive External Beam Radiation Therapy and Brachytherapy Cureus

Published: Aug. 13, 2025, 1:15 p.m.
Anatomic subtype-specific causal effects of endometriosis on ovarian cancer: a two-sample Mendelian randomization study.

While epidemiological studies have associated endometriosis with ovarian cancer risk, the causal relationships across anatomic subtypes and histotypes remain undefined. Using two-sample Mendelian randomization with 84 genetic instruments (F-statistic = …

Published: Aug. 13, 2025, midnight
Advanced Endometrial Cancer Pipeline Outlook Report 2025: Key 25+ Companies and Breakthrough Therapies Shaping the Future Landscape - Barchart.com

Advanced Endometrial Cancer Pipeline Outlook Report 2025: Key 25+ Companies and Breakthrough Therapies Shaping the Future Landscape Barchart.com

Published: Aug. 12, 2025, 10:38 p.m.
Pretreatment Inflammatory Indices as Predictors of Survival in Endometrial Cancer: A Retrospective Cohort Study From Mexico - Cureus

Pretreatment Inflammatory Indices as Predictors of Survival in Endometrial Cancer: A Retrospective Cohort Study From Mexico Cureus

Published: Aug. 12, 2025, 7:53 a.m.
Endometrial Cancer Cases Surging In Women? Expert Warns About Common Daily Habits That Can Be Hidden Triggers! - Boldsky

Endometrial Cancer Cases Surging In Women? Expert Warns About Common Daily Habits That Can Be Hidden Triggers! Boldsky

Published: Aug. 12, 2025, 5:05 a.m.
Decade of Pill Use Might Cut Endometrial Cancer Risk by Two-thirds – Semmelweis University - Semmelweis Egyetem

Decade of Pill Use Might Cut Endometrial Cancer Risk by Two-thirds – Semmelweis University Semmelweis Egyetem

Published: Aug. 12, 2025, 4 a.m.
TET3 is a common epigenetic immunomodulator of pathogenic macrophages.

Through a combination of single-cell/single-nucleus RNA-sequencing (sc/snRNA-seq) data analysis, immunohistochemistry, and primary macrophage studies, we have identified pathogenic macrophages characterized by TET3 overexpression (Toe-Macs) in three major human diseases associated …

Published: Aug. 12, 2025, midnight
Woman's Doctor: Ovarian cancer is very treatable if caught early. Know the symptoms - WBAL-TV

Woman's Doctor: Ovarian cancer is very treatable if caught early. Know the symptoms WBAL-TV

Published: Aug. 11, 2025, 9:37 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!